Main > ONCOLOGY (**) > Breast Cancer>HR+>HER2->MET>PM * > Treatment > Co: UK. A. Fulvestrant MonoTherapy

---

Co: UK. A. Fulvestrant MonoTherapy's subsections
(*) USA Approval Date: 2017. 08.28
Company
Patent>Assignee; Claims; No.; Etc.
Patent>USA Expiration: 2007. 12
TradeMark
TradeMark Web-Site

Co: UK. A. Fulvestrant MonoTherapy's products
This section has no products